Burning Rock Biotech Limited
BNR
$2.90
-$0.04-1.36%
NASDAQ
| 12/31/2024 | 09/30/2024 | 03/31/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -- | -- | -82.29M | -82.29M | -92.43M |
| Total Depreciation and Amortization | -- | -- | 18.21M | 18.21M | 18.21M |
| Total Amortization of Deferred Charges | -- | -- | 269.80K | 269.80K | 269.80K |
| Total Other Non-Cash Items | -- | -- | 45.36M | 45.36M | 44.57M |
| Change in Net Operating Assets | -- | -- | -7.22M | -7.22M | -7.22M |
| Cash from Operations | -- | -- | -25.67M | -25.67M | -36.61M |
| Capital Expenditure | -- | -- | -1.12M | -1.12M | -1.12M |
| Sale of Property, Plant, and Equipment | -- | -- | 11.60K | 11.60K | 11.60K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 41.00K | 41.00K | -220.00K |
| Cash from Investing | -- | -- | -1.07M | -1.07M | -1.33M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -6.98M | -6.98M | -6.98M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -41.82M | -41.82M | -41.86M |
| Cash from Financing | -- | -- | -6.74M | -6.74M | -6.75M |
| Foreign Exchange rate Adjustments | -- | -- | 1.28M | 1.28M | 553.90K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -- | -32.21M | -32.21M | -44.13M |